FIELD: medicine.
SUBSTANCE: invention relates to stable pharmaceutical composition, which contains as active ingredient phenylephrine in pharmaceutically effective amount and silicified microcrystalline cellulose in amount, effective for reduction of phenylephrine destruction, caused by exposure to oxygen.
EFFECT: phenylephrine tablets by invention demonstrate acceptable physical characteristics, such as form, colour, strength, and satisfactory stability profile.
9 cl, 2 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION AND METHOD WITH USING STABILISED SENSITIVE INGREDIENT | 2008 |
|
RU2466741C2 |
| DISPERSING TABLETS OF DEFERASIROX | 2005 |
|
RU2396954C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE | 2019 |
|
RU2781638C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DIACEREIN | 2009 |
|
RU2542461C2 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
| PEDIATRIC CAPECITABINE-CONTAINING TABLETS | 2007 |
|
RU2455979C2 |
| PHARMACEUTICAL DOSAGE FORMS AND COMPOSITIONS OF COLON ABSORBED PHENYLEPHRINE | 2007 |
|
RU2454225C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND, CONTAINING A GLUCOKINASE ACTIVATOR AND AN ALPHA-GLUCOSIDASE INHIBITOR, METHODS FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2775603C2 |
| SOLID OR SEMI-LIQUID TIME-RELEASE DOSAGE FORMS | 2008 |
|
RU2471480C2 |
| MEDICINE DELIVERY REGULATED SYSTEM CONTAINED IN STOMACH | 2002 |
|
RU2325152C2 |
